BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7911101)

  • 1. Postmenopausal endometrial hyperplasia: role of danazol therapy.
    Mariani L; Sedati A; Giovinazzi R; Sindico R; Atlante G
    Int J Gynaecol Obstet; 1994 Feb; 44(2):155-9. PubMed ID: 7911101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women.
    Soh E; Sato K
    Cancer; 1990 Sep; 66(5):983-8. PubMed ID: 2386926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of danazol therapy in postmenopausal women affected by endometrial hyperplasia.
    Sedati A; Mariani L; Giovinazzi R; Yacoub M; Atlante G
    Clin Exp Obstet Gynecol; 1992; 19(3):161-5. PubMed ID: 1451280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of danazol and tamoxifen on endometrial hyperplasia].
    Soh E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of endometrial hyperplasia with a danazol-releasing intrauterine device: a prospective study.
    Tamaoka Y; Orikasa H; Sumi Y; Sakakura K; Kamei K; Nagatani M; Ezawa S
    Gynecol Obstet Invest; 2004; 58(1):42-8. PubMed ID: 15087596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
    Jasonni VM; Naldi S; La Marca L; Bulletti C; Ciotti P; Vignudelli A; Flamigni C
    Cancer Detect Prev; 1986; 9(3-4):331-5. PubMed ID: 3742508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danazol reverses endometrial hyperplasia to normal endometrium.
    Bulletti C; Jasonni VM; Tabanelli S; Balducci M; Fuschini G; Flamigni C
    Acta Eur Fertil; 1987; 18(3):185-7. PubMed ID: 3439404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device.
    Tamaoka Y; Orikasa H; Sumi Y; Sakakura K; Kamei K; Nagatani M; Ezawa S
    Hum Cell; 2000 Sep; 13(3):127-33. PubMed ID: 11197774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal uterine bleeding: medical treatment with vaginal danazol and five-year follow-up.
    Mais V; Cossu E; Angioni S; Piras B; Floris L; Melis GB
    J Am Assoc Gynecol Laparosc; 2004 Aug; 11(3):340-3. PubMed ID: 15559345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysteroscopic pictures following danazol therapy in endometrial hyperplasia.
    Busacca M; Luchini S; Molinari MA; Tonta A; Marelli G
    Acta Eur Fertil; 1987; 18(3):197-201. PubMed ID: 3439406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia.
    Terakawa N; Inoue M; Shimizu I; Ikegami H; Mizutani T; Sakata M; Tanizawa O; Matsumoto K
    Cancer; 1988 Dec; 62(12):2618-21. PubMed ID: 3191463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological Pattern Of Endometrial Samples In Postmenopausal Women With Abnormal Uterine Bleeding.
    Deeba F; Shaista ; Khan B
    J Ayub Med Coll Abbottabad; 2016; 28(4):721-724. PubMed ID: 28586596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling.
    Rotenberg O; Fridman D; Doulaveris G; Renz M; Kaplan J; Gebb J; Xie X; Goldberg GL; Dar P
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):546-551. PubMed ID: 31389091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
    Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
    Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group.
    Terakawa N; Kigawa J; Taketani Y; Yoshikawa H; Yajima A; Noda K; Okada H; Kato J; Yakushiji M; Tanizawa O; Fujimoto S; Nozawa S; Takahashi T; Hasumi K; Furuhashi N; Aono T; Sakamoto A; Furusato M
    J Obstet Gynaecol Res; 1997 Jun; 23(3):223-30. PubMed ID: 9255033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of ultrasonography in diagnosis of atypical endometrial hyperplasia in postmenopausal women].
    Starczewski A; Brodowska A; Strojny K; Puchalski A; Mieczkowska E; Szydłowska I
    Przegl Lek; 2005; 62(4):227-9. PubMed ID: 16229240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium.
    Schmidt T; Breidenbach M; Nawroth F; Mallmann P; Beyer IM; Fleisch MC; Rein DT
    Maturitas; 2009 Feb; 62(2):176-8. PubMed ID: 19121901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of hysteroscopy to the detection malignancy in symptomatic postmenopausal women.
    Liberis V; Tsikouras P; Christos Z; Ammari A; Dislian V; Koutlaki N; Liberis A; Maroulis G
    Minim Invasive Ther Allied Technol; 2010 Apr; 19(2):83-93. PubMed ID: 20158408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
    Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
    Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.